PHASE III AXIS TRIAL OF AXITINIB VERSUS SORAFENIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: ASIAN SUBGROUP ANALYSISH. Uemura, Y. -C. Ou,H. Y. Lim,Y. Tomita,T. Ueda,H. Menon,J. Chung, J. Guo,J. Tarazi,S. Kim,S. Naito,H. AkazaAnnals of Oncology(2012)引用 2|浏览19暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要